Stock BLGO BIOLARGO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News BioLargo, Inc.

Equities

BLGO

US09065A1007

Market Closed - OTC Markets
Other stock markets
 03:15:29 2024-07-08 pm EDT 		5-day change 1st Jan Change
0.2699 USD +4.45% Intraday chart for BioLargo, Inc. +3.81% +60.65%
Jun. 11 BioLargo, Inc. Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-Ion CI
May. 14 Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
BioLargo, Inc. Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-Ion
CI
Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BioLargo to Present at The LD Micro Invitational XIV
NE
New Regulations May Be Coming To Combat Dangerous “Forever Chemicals” – This Cleantech Innovator Is Ready
AQ
Biolargo Equipment Solutions & Technologies, Inc Appoints Sally Gutierrez to the Board of Directors
CI
BioLargo, Inc. Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment
CI
BioLargo, Inc. announced that it has received $0.815 million in funding
CI
BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey
CI
BioLargo, Inc. cancelled the transaction announced on December 13, 2022
CI
Transcript : BioLargo, Inc., Q3 2023 Earnings Call, Nov 20, 2023
BioLargo, Inc. announced that it expects to receive $0.815 million in funding
CI
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
BioLargo, Inc. to Present at the LD Micro Main Event XVI
NE
Transcript : BioLargo, Inc., Q2 2023 Earnings Call, Aug 16, 2023
BioLargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
BioLargo, Inc. Discusses Record-Breaking Financial Results, Innovation-Pipeline Business Model, and More with The Stock Day Podcast
NE
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLGO Stock
  4. News BioLargo, Inc.